Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience
dc.contributor.author | Baptista, Daniela [UNESP] | |
dc.contributor.author | Bussadori, Karina | |
dc.contributor.author | Nunes-de-Souza, Ricardo Luiz [UNESP] | |
dc.contributor.author | Canto-de-Souza, Azair [UNESP] | |
dc.contributor.institution | Universidade Federal de São Carlos (UFSCar) | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-20T13:25:00Z | |
dc.date.available | 2014-05-20T13:25:00Z | |
dc.date.issued | 2009-10-06 | |
dc.description.abstract | Intra-amygdala infusion of midazolam, a benzodiazepine receptor agonist, produces anxiolytic-like effects in mice when first exposed to the elevated plus-maze (EPM) and blocks antinociception induced in mice confined in the open arm of the EPM. However, benzodiazepines fail to alter anxiety in maze-experienced rodents, a phenomenon defined as "one-trial tolerance" (OTT). The main purpose of the present study was to investigate whether intra-amygdala midazolam attenuates the open ann-induced antinociception (OAA) in maze-experienced mice. Nociception was assessed by the writhing test (intraperitoneal injection of 0.6% acetic acid). In Experiment 1, nociception was recorded in maze-experienced mice without prior drug treatment. Experiment 2 investigated the effects of systemic midazolam (0.5, 1.0 and 2.0 mg/kg, s.c.), injected before EPM trial 2, on OAA in maze-experienced mice. in Experiment 3, the effects on OAA of intra-amygdala midazolam (30 nmol/0.1 mu l), injected before trial 1 (maze-naive) or before trial 2 (maze-experienced), were observed. The effects on OAA of intra-amygdala midazolam injected before trial 1 and trial 2 were also investigated (Experiment 4). The results showed that OAA remained unchanged in maze-experienced mice and was insensitive to systemic midazolam. However, intra-amygdala midazolam attenuated OAA in maze-naive mice, but not in maze-experienced mice. Even when given before both trial 1 and trial 2, intra-amygdala midazolam failed to alter OAA in maze-experienced mice. Taken together, these results confirm that the GABA(A)/benzodiazepine receptor complex located within the amygdala plays a role in OAA in maze-naive mice. The lack of effects following systemic or intra-amygdala midazolam on OAA in maze-experienced mice suggests that the OTT is also observed in the modulation of nociception and that the GABA(A)/benzodiazepine receptor located within this limbic forebrain structure participates in this process. (C) 2009 Elsevier B.V. All rights reserved. | en |
dc.description.affiliation | Universidade Federal de São Carlos (UFSCar), CECH, Dept Psicol, Grp Psicobiol, BR-13565905 São Carlos, SP, Brazil | |
dc.description.affiliation | Universidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil | |
dc.description.affiliation | São Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil | |
dc.description.affiliationUnesp | Universidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil | |
dc.description.affiliationUnesp | São Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipId | FAPESP: 06/06855-4 | |
dc.description.sponsorshipId | CNPq: 309407/2006-0 | |
dc.format.extent | 29-37 | |
dc.identifier | http://dx.doi.org/10.1016/j.brainres.2009.07.055 | |
dc.identifier.citation | Brain Research. Amsterdam: Elsevier B.V., v. 1294, p. 29-37, 2009. | |
dc.identifier.doi | 10.1016/j.brainres.2009.07.055 | |
dc.identifier.issn | 0006-8993 | |
dc.identifier.uri | http://hdl.handle.net/11449/7906 | |
dc.identifier.wos | WOS:000270658500004 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Brain Research | |
dc.relation.ispartofjcr | 3.125 | |
dc.relation.ispartofsjr | 1,404 | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Web of Science | |
dc.subject | Fear | en |
dc.subject | Antinociception | en |
dc.subject | Amygdala | en |
dc.subject | Midazolam | en |
dc.subject | Elevated plus-maze | en |
dc.subject | Mice | en |
dc.title | Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience | en |
dc.type | Artigo | pt |
dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dcterms.rightsHolder | Elsevier B.V. | |
dspace.entity.type | Publication | |
relation.isOrgUnitOfPublication | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |
unesp.department | Princípios Ativos Naturais e Toxicologia - FCF | pt |
Arquivos
Licença do pacote
1 - 2 de 2
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: